Skip Navigation

Practice Location

Add a Location+

Language

Add a Language+
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    P
    R
    S
    T
    U
    V
    Y

Doctor's Gender

Doctor Results for Cancer Risk

Displaying 21 to 40 of 144
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Results per page: 10 ·  20 

  • Phillip Martin Pierorazio, M.D.

    disease and high-risk surgeries for patients with advanced cancers. His research interests...

    Dr. Phillip Pierorazio is an Associate Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University.  Dr. Pierorazio is originally from New York, received his undergraduate degree from Georgetown University in ...
  • Amol Kumar Narang, M.D.

    Radiation therapy; gastrointestinal cancers; pancreatic cancer; colorectal cancer; stereotactic body radiation...

    Make A GiftDr. Narang is an Instructor in the Johns Hopkins Department of Radiation Oncology & Molecular Sciences. A former chief resident in the department, Dr. Narang now specializes in radiation treatment for gastrointestinal malignancies, inc...
  • Trinity Jude Bivalacqua, M.D., Ph.D.

    AE. "Very-high-risk localized prostate cancer: definition and outcomes." Prostate Cancer Prostatic Dis. 2013...

    Trinity J. Bivalacqua, M.D., Ph.D., is the R. Christian B. Evensen Professor of Urology and Oncology and Director of Urologic Oncology at the James Buchanan Brady Urologic Institute.  He was born in New Orleans, Louisiana and graduated from Tula...
  • Channing Judith Paller, M.D.

    NF, Hudson TS. Risk of Prostate Cancer in African American...

    Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and an associate professor of oncology at the Johns Hopkins University School of Medicine. She is board certified in internal medicine and medical oncology and practices out o...
  • Alan Wayne Partin, M.D., Ph.D.

    AE. "Very-high-risk localized prostate cancer: definition and outcomes." Prostate Cancer Prostatic Dis. 2014...

    Dr. Alan W. Partin is The Jakurski Family Director of the Brady Urological Institute, Urologist-In-Chief of Johns Hopkins Medicine and professor of Urology, Pathology and Oncology.  He is a prostate surgeon and researcher at The Johns Hopkins Ho...
  • Mark Christopher Markowski, M.D., Ph.D.

    numerous types of cancers, with a specialty in prostate cancer. Dr. Markowski earned...

    Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary...
  • Stephen Joseph Meltzer, M.D.

    early detection of cancer, outcomes research in cancer and precancer, risk stratification prediction in cancer and precancer, Barrett...

    Dr. Stephen J. Meltzer is a Professor of Medicine and Oncology at Johns Hopkins University, Division of Gastroenterology. He is the Director of GI Early Detection Biomarkers Laboratory and a member of the Johns Hopkins Kimmel Cancer Center. His resea...
  • John H Fetting, M.D.

    is at sufficient risk for breast cancer to drive action...

    John Fetting, a 30-year veteran of the Johns Hopkins faculty, readily discusses the dramatic changes in the treatment of breast cancer that have evolved during his tenure, such as how clinicians now choose a treatment protocol based on the biological...
  • Francis Michael Giardiello, M.D.

    Family History of Cancer, Gastroenterology, Gastrointestinal Cancers, Hereditary Colorectal Cancer, Rectal Bleeding ...read...

    Dr. Giardiello was graduated from Tufts University School of Medicine and has a MBA from Johns Hopkins University. He received his internal medicine training at The University of Michigan and fellowship training in Gastroenterology at The Johns Hopki...
  • Misop Han, M.D.

    prostatectomy for high-risk prostate cancer." BJU Int. 2013...

    Dr. Misop Han is David Hall McConnell Professor of Urology and Oncology at the Johns Hopkins School of Medicine. Dr. Han is a board-certified urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney...
  • Marcia Irene Canto, M.D.

    Disease (GERD), Gastrointestinal Cancers, Pancreatic and Biliary Disease, Pancreatic Cancer, Pancreatic Cysts ...read...

    Marcia (Mimi) Canto, M.D., M.H.S. is a Professor of Medicine at The Johns Hopkins University School of Medicine. She is also the Director of Endoscopy at the Johns Hopkins Hospital. Dr. Canto received her Bachelor of Science degree from the Universit...
  • James Stuart Ferriss, M.D.

    Male Expertise Cervical Cancer, Endometrial Cancer, Gynecologic Cancers, Gynecologic Oncology, High Risk Endometrial (Uterine) Cancer, Minimally Invasive Surgery, Ovarian Cancer, Robotic Surgery, Uterine Cancer, Vulvar Cancer ...read more Dr...

    James Stuart Ferriss is an assistant professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program.He is an expert in the care of women with cancers of the uterus, c...
  • B Douglas Smith, M.D.

    adults with poor-risk acute myelogenous leukemia. Clin Cancer Res. 2007 Aug...

  • Adrian Sandra Dobs, M.D., M.H.S.

    Therapy Increase the Risk of Prostate Cancer?Endocr.Prac.,2008...

    Dr. Dobs is presently an active investigator in the field of male gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging. her clinical...
  • Ephraim Joseph Fuchs, M.D.

    secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev...

  • Michael Lim, M.D.

    Rindopepimut Cuts Death Risk From Brain Cancer, Study Shows, Wall...

    Dr. Michael Lim's surgical interest is in the treatment of primary and metastatic brain tumors as well as pituitary and skull base tumors. He also has an interest in surgical treatments of trigeminal neuralgia. He utilizes the most advanced technique...
  • Allen Ray Sing Chen, M.D., M.H.S., Ph.D.

    patients with high risk osteosarcoma. Cancer 2010 Dec 1...

    Chen's primary area of research focuses on bone marrow transplantation (BMT), a highly complex and specialized aspect of pediatric oncology that, in recent years, has become an accepted form of therapy for an increasingly broad range of cancers. In a...
  • Michael Adam Gorin, M.D.

    men with high-risk prostate cancer: results of a...

  • Martin Adel Makary, M.D., M.P.H.

    Research Interests Operative Risk Assessment in the Elderly; Cancer Therapy; Minimally-Invasive...

    Dr. Makary is a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center.  He is a clinical lead for the Johns Hopkins Sibley Innovation Hub and serves as Executive Director of Improving Wisely, a Robert Wood Johnson Foundation...
  • Jaishri O'Neill Blakeley, M.D.

    -1 may increase risk of breast cancer in women, Net...

    Dr. Jaishri Blakeley is a Professor of Neurology, Oncology and Neurosurgery (Neuro-oncology). She is the Director of the Johns Hopkins Comprehensive Neurofibromatosis Center, and Director of the United Counsel of Neurolgic Subspecialties (UCNS) Neuro...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
back to top button